Crossmark

Dalbavancin as consolidation antibiotic treatment in infective endocarditis, cardiac implantable electronic devices infection and bacteremia: Clinical experience of 7 years

Crossref DOI link: https://doi.org/10.1016/j.eimce.2024.05.009

Published Print: 2025-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Salinas-Botrán, Alejandro

Olmos-Blanco, Carmen

Fernández de Velasco-Pérez, David

Guzmán-Carreras, Alicia

Morales-Rosas, Alejandro

Gómez-Ramírez, Daniel
License Information

Text and Data Mining valid from 2025-02-01

Text and Data Mining valid from 2025-02-01
More Information

This article is maintained by: Elsevier

Article Title: Dalbavancin as consolidation antibiotic treatment in infective endocarditis, cardiac implantable electronic devices infection and bacteremia: Clinical experience of 7 years

Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2024.05.009

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eimc.2024.02.010

Content Type: article

Copyright: © 2024 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below